Sign in
4/A

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-19-000041

Sr. VP & General Counsel acquired 3,295 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Gardiner Nathaniel S. · Sr. VP & General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-06-26 Exercise or conversion : show line 1 in the form +3,295 $31.42 $103,529 13,147 D
Loading xslF345X03/edgar.xml…